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Andreia C. Gomes 1, and Margarida Casal 1 
 
1CBMA (Centre of Molecular and Environmental Biology), Department of Biology, University 
of Minho, Campus de Gualtar, 4710-057 Braga, Portugal 
2School of Chemistry, Bharathidasan University, Tiruchirappalli − 620 024, India 
3BioPhotonics Group, Nanomedicine Department, International Iberian Nanotechnology 
Laboratory (INL), P-4715-310 Braga, Portugal 
4Faculty of Medicine, Aalborg University, DK-9220 Aalborg, Denmark 
5Bioforge (Group for Advanced Materials and Nanobiotechnology), Centro I+D, Universidad de 
Valladolid, Valladolid, Spain 
6Networking Research Centre on Bioengineering, Biomaterials and Nanomedicine (CIBER-
BBN), E-47011 Valladolid, Spain 
 
The spread of antimicrobials resistant microorganisms has triggered the search for new 
ways to treat infections. In the present work we explored the ABP-CM4 peptide 
properties from Bombyx mori for the creation of biopolymers with broad antimicrobial 
activity. An antimicrobial recombinant protein-based polymer (rPBP) was designed by 
cloning the DNA sequence coding for ABP-CM4 in frame with the N-terminus of the 
elastin-like recombinamer consisting of 200 repetitions of the pentamer VPAVG, here 
named A200. The new rPBP, named CM4-A200, was purified via a simplified 
nonchromatographic method, making use of the thermoresponsive behavior of the A200 
polymer. ABP-CM4 peptide was also purified through the incorporation of a formic 
acid cleavage site between the peptide and the A200 sequence. In soluble state the 
antimicrobial activity of both CM4-A200 polymer and ABP-CM4 peptide was poorly 
effective. However, when the CM4-A200 polymer was processed into free-standing 
films high antimicrobial activity against Gram-positive and Gram-negative bacteria, 
yeasts and filamentous fungi was observed. The antimicrobial activity of CM4-A200 
was dependent on the physical contact of cells with the film surface. Furthermore, 
CM4- A200 films did not reveal a cytotoxic effect against both normal human skin 
fibroblasts and human keratinocytes. Finally, we have developed an optimized ex vivo 
assay with pig skin demonstrating the antimicrobial properties of the CM4-A200 cast 
films for skin applications. 
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